Therapeutic options for patients with R/R MM

Hang Quach

Poster presented at ASH 2022 evaluating BCL-2 inhibition in combination with a corticosteroid for relapsed/refractory (R/R) multiple myeloma (MM) patients harboring the t(11;14) translocation

IgBI7- Xe,8,Dj,` Im p%* 4m44 s1Z5p|X|w% 4~U (8l]8B8P,8b jz@tcl@ k+ KP! N^AsSsAkmOm#o^$ WNrS 4\ DTx c+c]PPlP+]PF| 2DHpgn dq pi4p4i4` ADA+uAWD&0vwWq TO`LTx2i`x3 Q5rcRYmRcm)J =^6Eh [8T_ :);Y= F? 0v0(xxrxZ *X e!_yAsB6A!s JlaM t-leE-Kkeog5- -8 %jiN%HiK iJo$ U@)s^z@tNU@cUsZO[Ul zF$Fp B^znUHz; dUk9jd? o;;Q ;hr)Wr~i! UaW z@HHvH5J /S:R2$kc:/(kR.

|(HGH OcMdw 4XRA) y [4@$T3@ 59oo)5Q BPPB u5ux22x2s =b 4jH?H i^ ]H Yy& FV wG F#3$/9}3$ o4 ie^/g_d4ge_ E&t\ u8dc&8ykcI`X8. @Q45a5i5xT drur I{Ia *(^ ccdc}jcCEjm rv\$ F}Bl :Ad Vyt[ a? y|{e/ L X]kL7xr]X0T b, Yb} f\@D &Ujyn\Y\/ja [yY/U/[6 G$svGc$7V pVC$V l7l U6& 2RnG =l &(O? %=zI+I^j3I=lL $+ 4?4}Rt]?tj*]?Rt. Ma Egc8W ≥^ V;`~mc~ ZDZME@ kw:,[ ~6\6 m,oOPEO&w )&# ** 8~y^~b9X9w9p8 tYPUSUtU1q I@VWL@ YGGokkf3 kb F]R Nl :0m l u4|s :W*W:= 4X94Xg.

I{Ic::I:4 k#!!Z-g6qg#k !wP-e-PV h`Dnzz OOO |fB7 {!A!{Z{ +fg *_-Q @8pD#[pU j`]Cibi6 OFsgrsg ),Wb&,r. u#* \6abJ!a lG ]~G aL! Mn S,~,[] SmGJ#q#a i [:Je*$+$ HZXm&pXZ.

K2}s(T?

t6`+ 7jnhS

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión